HPCAL1 presented a remarkably poor overall survival (OS) and relapse‐free survival (RFS) probability along with a significant differential expression in CCA (Figure 2B,C), whereas the differential expression trend and RFS probability of CDH6 in CCA were disappointing (Figure 2E,F). This evidence concerns the gene HPCAL1 and cholangiocarcinoma.